MedTrace Logo

Postoperative Dexamethasone on Post-Cesarean Pain

NCT04067609 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-05-16

Study results available
· View outcomes & findings →

Summary

Investigating if giving post-operative dexamethasone to patients with a history of opioid use disorder on medication assisted treatment during pregnancy improves their pain scores and decreases their opioid use after cesarean section.

Conditions

  • Post-Cesarean Pain
  • Cesarean Section Complications

Interventions

DRUG

Dexamethasone

subjects will receive a single administration of either 0.1 mg/kg of intravenous dexamethasone in 90mL of normal saline

OTHER

placebo

100mL of normal saline (placebo)

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Victoria Wesevich, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2024-04-01
Completion
2024-04-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04067609 on ClinicalTrials.gov